Globus Medical, Inc. (GMED)

Globus Medical Stock Forecast

Stock Price Forecast

The 11 analysts that cover Globus Medical stock have a consensus rating of "Buy" and an average price target of $88.09, which forecasts a 5.01% increase in the stock price over the next year. The lowest target is $64 and the highest is $115.

Price Target: $88.09 (+5.01%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$64	$88.09	$91	$115
Change	-23.71%	+5.01%	+8.48%	+37.08%

Analyst Ratings

The average analyst rating for Globus Medical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jun '25	Jul '25	Aug '25	Sep '25	Oct '25	Nov '25
Strong Buy	3	3	3	3	3	5
Buy	5	5	5	5	5	5
Hold	5	5	5	5	6	4
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	13	13	13	13	14	14

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Shagun Singh RBC Capital	RBC Capital	Buy Maintains $88 → $92	Buy	Maintains	$88 → $92	+9.67%	Nov 7, 2025
Vik Chopra Wells Fargo	Wells Fargo	Buy Maintains $66 → $79	Buy	Maintains	$66 → $79	-5.83%	Nov 7, 2025
Craig Bijou B of A Securities	B of A Securities	Hold → Strong Buy Upgrades $65 → $91	Hold → Strong Buy	Upgrades	$65 → $91	+8.48%	Nov 7, 2025
Richard Newitter Truist Securities	Truist Securities	Hold → Strong Buy Upgrades $65 → $93	Hold → Strong Buy	Upgrades	$65 → $93	+10.86%	Nov 7, 2025
Thomas Stephan Stifel	Stifel	Hold Initiates $64	Hold	Initiates	$64	-23.71%	Oct 28, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

2.91B

Increased by 15.59%

from 2.52B

Revenue Next Year

3.14B

Increased by 7.97%

from 2.91B

EPS This Year

3.27

Increased by 335.89%

from 0.75

EPS Next Year

3.72

Increased by 13.74%

from 3.27

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	789.04M	958.10M	1.02B	1.57B	2.52B	2.91B	3.14B
Revenue Growth	0.47%	21.43%	6.76%	53.35%	60.62%	15.59%	7.97%
EPS	1.01	1.44	1.85	1.07	0.75	3.27	3.72
EPS Growth	-33.55%	42.57%	28.47%	-42.16%	-29.91%	335.89%	13.74%
Forward PE	-	-	-	-	-	25.66	22.56
No. Analysts	-	-	-	-	-	16	16

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	3.0B	3.3B
Avg	2.9B	3.1B
Low	2.8B	2.9B

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	20.1%	13.6%
Avg	15.6%	8.0%
Low	10.7%	1.1%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	3.42	4.36
Avg	3.27	3.72
Low	3.09	3.31

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	356.4%	33.3%
Avg	335.9%	13.7%
Low	311.6%	1.3%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.